XTANT MEDICAL HOLDINGS, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $17.83 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-08
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $17.83M, a 18.94% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $19.53M, a 19.84% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $19.62M, a 14.36% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $21.37M, a 0.28% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $82.51M, a 7.69% decline from fiscal 2016.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $89.39M, a 53.60% increase from fiscal 2015.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $58.19M, a 68.34% increase from fiscal 2014.
- XTANT MEDICAL HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $34.57M, a 6.16% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $17.83M 10-Q · filed 2018-05-08 | $37.36M derived: sum of 2 quarters · filed 2018-05-08 | $56.98M derived: sum of 3 quarters · filed 2018-05-08 | $78.35M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-12-31 | $19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-05 | $39.15M derived: sum of 2 quarters · filed 2018-04-05 | $60.52M derived: sum of 3 quarters · filed 2018-04-05 | $82.51M 10-K · filed 2018-04-05 | |
| 2017-09-30 | $19.62M 10-Q · filed 2017-11-21 | $40.99M derived: sum of 2 quarters · filed 2018-03-30 | $62.99M 10-Q · filed 2017-11-21 | $87.35M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-06-30 | $21.37M 10-Q · filed 2018-03-30 | $43.37M 10-Q · filed 2018-03-30 | $67.73M derived: sum of 3 quarters · filed 2018-05-08 | $90.64M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-03-31 | $22.00M 10-Q · filed 2018-05-08 | $22.00M 10-Q · filed 2017-05-15 | $46.36M derived: sum of 2 quarters · filed 2018-05-08 | $69.27M derived: sum of 3 quarters · filed 2018-05-08 | $90.58M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $24.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-05 | $47.27M derived: sum of 2 quarters · filed 2018-04-05 | $68.58M derived: sum of 3 quarters · filed 2018-04-05 | $89.39M 10-K · filed 2018-04-05 | |
| 2016-09-30 | $22.91M 10-Q · filed 2017-11-21 | $44.22M derived: sum of 2 quarters · filed 2018-03-30 | $65.03M 10-Q · filed 2017-11-21 | $86.79M derived: sum of 4 quarters · filed 2018-03-30 | |
| 2016-06-30 | $21.31M 10-Q · filed 2018-03-30 | $42.12M 10-Q · filed 2018-03-30 | $63.88M derived: sum of 3 quarters · filed 2018-03-30 | $81.30M derived: sum of 4 quarters · filed 2018-03-30 | |
| 2016-03-31 | $20.81M 10-Q · filed 2018-03-30 | $42.57M derived: sum of 2 quarters · filed 2018-03-30 | $59.99M derived: sum of 3 quarters · filed 2018-03-30 | $69.73M derived: sum of 4 quarters · filed 2018-03-30 | |
| 2015-12-31 | $21.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $39.18M derived: sum of 2 quarters · filed 2017-03-29 | $48.92M derived: sum of 3 quarters · filed 2017-03-29 | $58.19M 10-K · filed 2017-03-29 | |
| 2015-09-30 | $17.42M 10-Q · filed 2016-11-10 | $27.15M derived: sum of 2 quarters · filed 2016-11-10 | $36.43M 10-Q · filed 2016-11-10 | $45.29M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $9.73M 10-Q · filed 2016-08-10 | $19.01M 10-Q · filed 2016-08-10 | $27.87M derived: sum of 3 quarters · filed 2016-08-10 | $36.11M derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | $9.28M 10-Q · filed 2016-05-11 | $18.13M derived: sum of 2 quarters · filed 2016-05-11 | $26.38M derived: sum of 3 quarters · filed 2016-05-11 | $35.09M derived: sum of 4 quarters · filed 2016-05-11 | |
| 2014-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $17.10M derived: sum of 2 quarters · filed 2016-03-24 | $25.82M derived: sum of 3 quarters · filed 2016-03-24 | $34.57M 10-K · filed 2016-03-24 | |
| 2014-09-30 | $8.25M 10-Q · filed 2015-11-16 | $16.96M derived: sum of 2 quarters · filed 2015-11-16 | $25.71M 10-Q · filed 2015-11-16 | $33.85M derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | $8.71M 10-Q · filed 2015-08-14 | $17.47M 10-Q · filed 2015-08-14 | $25.60M derived: sum of 3 quarters · filed 2015-08-14 | $33.31M derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $8.75M 10-Q · filed 2015-05-06 | $16.89M derived: sum of 2 quarters · filed 2015-05-06 | $24.60M derived: sum of 3 quarters · filed 2015-05-06 | $32.79M derived: sum of 4 quarters · filed 2015-05-06 | |
| 2013-12-31 | $8.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $15.84M derived: sum of 2 quarters · filed 2015-03-18 | $24.04M derived: sum of 3 quarters · filed 2015-03-18 | $32.56M 10-K · filed 2015-03-18 | |
| 2013-09-30 | $7.71M 10-Q · filed 2014-11-07 | $15.91M derived: sum of 2 quarters · filed 2014-11-07 | $24.43M 10-Q · filed 2014-11-07 | $32.42M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-06-30 | $8.20M 10-Q · filed 2014-08-14 | $16.72M 10-Q · filed 2014-08-14 | $24.71M derived: sum of 3 quarters · filed 2014-08-14 | $33.35M derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | $8.52M 10-Q · filed 2014-05-12 | $16.51M derived: sum of 2 quarters · filed 2014-05-12 | $25.15M derived: sum of 3 quarters · filed 2014-05-12 | $33.27M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $16.63M derived: sum of 2 quarters · filed 2014-03-27 | $24.74M derived: sum of 3 quarters · filed 2014-03-27 | $32.41M 10-K · filed 2014-03-27 | |
| 2012-09-30 | $8.64M 10-Q · filed 2013-11-14 | $16.76M derived: sum of 2 quarters · filed 2013-11-14 | $24.43M 10-Q · filed 2013-11-14 | $33.61M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $8.11M 10-Q · filed 2013-08-13 | $15.78M 10-Q · filed 2013-08-13 | $24.97M derived: sum of 3 quarters · filed 2013-05-10 | $32.20M derived: sum of 4 quarters · filed 2013-05-10 | |
| 2012-03-31 | $7.67M 10-Q · filed 2013-05-10 | $16.85M derived: sum of 2 quarters · filed 2013-05-10 | $24.09M derived: sum of 3 quarters · filed 2013-05-10 | $31.46M derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $16.42M derived: sum of 2 quarters · filed 2013-03-27 | $23.79M derived: sum of 3 quarters · filed 2013-03-27 | $29.66M 10-K · filed 2013-03-27 | |
| 2011-09-30 | $7.24M 10-Q · filed 2012-11-08 | $14.61M derived: sum of 2 quarters · filed 2012-11-08 | $20.48M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $7.37M 10-Q · filed 2012-08-10 | $13.24M 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |